The Michael J. Fox Foundation’s Edmond J. Safra Fellowship in Movement Disorders expands internationally

The Michael J. Fox Foundation’s Edmond J. Safra Fellowship in Movement Disorders expands internationally

The Edmond J. Safra Fellowship in Movement Disorders was established in 2014 to train neurological clinician researchers for better Parkinson disease patient care. Its goal is to reach 72 graduates by the year 2028.

The Fellowship has recently selected a new group for this training, reflecting a growing global footprint of the program.

  • Sergio A. Castillo-Torres, Servicio de Movimientos Anormales, Buenos Aires, Argentina
  • Stephen Joza, Montreal Neurological Institute at McGill University, Canada
  • Francesca Magrinelli, UCL Queen Square Institute of Neurology, London, England
  • Poornima Menon, Hôpital Pitié-Salpétrière, Paris, France
  • Andrea Yoo, Mount Sinai Beth Israel, New York, USA

According to an announcement from the Michael J. Fox Foundation, the Edmond J. Safra Fellowship and the advancements of most promising Parkinson’s research to date have been made possible “through the leadership and transformative generosity of the late Mrs. Lily Safra, former chairwoman of the Edmond J. Safra Foundation and MJFF Board member“.

In 2021, Mrs. Safra commented on the impact of the Fellowship: “This growing global network of expertly trained movement disorder specialists will help ensure that people and families living with Parkinson’s receive comprehensive and compassionate care and that critical research moves forward to meet their most pressing needs. I’m deeply proud of The Edmond J. Safra Fellowship’s significant impact on Parkinson’s care and research.

The Michael J. Fox Foundation also salutes the role of the Edmond J. Safra Foundation in supporting improved care for Parkinson patients and research in movement disorders:
As one of the earliest and most supportive champions of The Michael J. Fox Foundation’s mission, the Edmond J. Safra Foundation through this program has made significant contributions in enhancing access to high-quality patient care and leading scientific advancements toward better understanding and treatment of movement disorders—an urgent need as the number of people with Parkinson’s increases around the world”.

Share this post